Moab Capital Partners’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-55,734
Closed -$775K 29
2014
Q1
$775K Buy
+55,734
New +$775K 0.34% 27